First Drug For 2 Forms Of MS Gets FDA Nod, RTTR Abuzz, VRTX Gains On Trial Data

The FDA has approved Roche's OCREVUS for relapsing and primary progressive forms of multiple sclerosis.

from RTT - Biotech http://ift.tt/2nfVEEH
via IFTTT